A.P. Pharma announces it plans to price a public sale of common stock

Offering will be conducted by bookrunners Jefferies and Leerink Swann

By Devika Patel

Knoxville, Tenn., Nov. 19 - A.P. Pharma, Inc. said it will price a public offering of common stock with a 30-day greenshoe.

Jefferies LLC and Leerink Swann LLC are the joint bookrunning managers; JMP Securities LLC, Oppenheimer & Co. and Brean Capital, LLC will be co-managers.

Proceeds will be used for development of Sustol, the company's drug candidate for the treatment of chemotherapy-induced nausea and vomiting, and general corporate and working capital purposes.

A.P. Pharma is a Redwood City, Calif., specialty pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.